2.5. Safety Assessment
liver and renal function
ADVERSE EVENTS
At visits 1 (week 0) and 4 (week 12), the safety of the investigated food supplements was evaluated by monitoring all adverse events (AEs), vital signs, blood pressure, pulse rate, body weight, urine analysis, hematological and blood chemistry tests (liver and renal function) of the subjects.